Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioPortfolio's Approved Drugs Database

Mellaril

Thioridazine Hydrochloride

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Press Releases About Mellaril:

BioPortfolio Logo
Lilly Resubmits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration 3rd June, 2009 Eli Lilly and Company
INDIANAPOLIS, June 3 /PRNewswire-FirstCall/ -- As projected, Eli Lilly and Company (NYSE: LLY) has resubmitted its supplemental New Drug Application (sNDA) for Cymbalta(R) (duloxetine HCl) for the
Cymbalta(R) Significantly Reduced Osteoarthritis Knee Pain in New Study 30th January, 2009 Eli Lilly and Company
INDIANAPOLIS, Jan. 30 /PRNewswire-FirstCall/ -- In a new study, Cymbalta (duloxetine HCl) 60-120 mg, taken once daily, reduced pain severity significantly, compared with placebo, in patients with
Use of Atypical Antipsychotic Drugs Increases Risk of Sudden Cardiac Death in Adults 14th January, 2009 Agency for Healthcare Research & Quality
ROCKVILLE, Md., Jan 14 /PRNewswire-USNewswire/ -- Patients ages 30 to 74 who took atypical antipsychotics such as risperidone (sold as Risperdal), quetiapine (Seroquel), olanzapine (Zyprexa) and
Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 28th November, 2008 Eli Lilly and Company
INDIANAPOLIS, Nov. 28 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) has withdrawn its supplemental New Drug Application (sNDA) from the U.S. Food and Drug Administration (FDA) for
Patients Taking Cymbalta(R) Experienced Reduced Chronic Low Back Pain in New Study 25th August, 2008 Eli Lilly and Company
INDIANAPOLIS, Aug. 25 /PRNewswire/ -- Data from a new study suggest that Cymbalta (duloxetine HCl) 60-120 mg once daily significantly reduced chronic low back pain, as measured by the Brief Pain

This page has been viewed 23 times
Recent Search Terms used to find this page: mellaril drug | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Mellaril across BioPortfolio, or for Mellaril Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.